Evidence map›Paper›PMID 36189168›Full record

ArticleDEN open2023

Potential significance of uncovered self-expandable metal stents for distal malignant biliary obstruction: A propensity score-adjusted competing risk regression analysis.

Yuichi Torisu, Masafumi Chiba, Masayuki Kato, Yuji Kinoshita, Takafumi Akasu, Tomoya Kanai, Yoichi Tomita, Nana Shimamoto, Takahiro Abe, Keisuke Kanazawa and 5 more

Abstract read
In one paragraph

Article in DEN open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuichi TorisuDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.ORCID https://orcid.org/0000-0002-2349-8855
Masafumi ChibaDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.
Masayuki KatoDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.
Yuji KinoshitaDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.
Takafumi AkasuDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.
Tomoya KanaiDepartment of Internal Medicine Division of Gastroenterology, Fuji City General Hospital Shizuoka Japan.
Yoichi TomitaDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.
Nana ShimamotoDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.
Takahiro AbeDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.
Keisuke KanazawaDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.
Shintaro TsukinagaDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.
Masanori NakanoDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.
Chisato SaekiDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.
Kazuki SumiyamaDepartment of Endoscopy The Jikei University School of Medicine Tokyo Japan.ORCID https://orcid.org/0000-0002-7976-6070
Masayuki SarutaDepartment of Internal Medicine Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Tokyo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Selection criteria for self-expandable metal stents (SEMSs) with or without cover during palliative treatment of distal malignant biliary obstruction (DMBO) remain unclear. We evaluated factors associated with time to recurrent biliary obstruction (TRBO) in fully covered SEMSs (FCSEMSs) and uncovered SEMSs (UCSEMSs). Methods: We retrospectively analyzed consecutive patients with DMBO who received a SEMS. TRBO was determined using the Kaplan-Meier analysis, and complications were compared between the FCSEMS and UCSEMS groups. After TRBO-associated factors were extracted using multivariate competing-risks regression (CRR), propensity score-adjusted CRRs were performed to verify their robustness. Results: There were 180 patients (66 FCSEMSs and 114 UCSEMSs) enrolled in this study. There was no significant difference between median TRBO in the FCSEMS and UCSEMS groups (275 vs. 255 days, Conclusions: UCSEMSs are a possible option for both patients with DMBO arising from PDAC and for patients with any DMBO receiving palliative care who should avoid SEMS-related complications.

Indexed as

covered self‐expandable metal stentdistal malignant biliary obstructionproper usetime to recurrent biliary obstructionuncovered self‐expandable metal stent

Identifiers

PMID36189168
PMCPMC9490143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.